Chikungunya vaccine trial for kids withdrawn before starting
NCT ID NCT07133178
First seen Sep 30, 2025 · Last updated May 23, 2026 · Updated 35 times
Summary
This study was designed to test a chikungunya vaccine (VLA1553) in healthy children aged 1 to 11 years. The goal was to see if the vaccine triggers a strong immune response and is safe compared to a standard vaccine. However, the trial was withdrawn before any participants were enrolled.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHIKUNGUNYA VIRUS INFECTION are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
Explore the condition pages connected to this study.